Metabotropic glutamate receptor 1a (mGluR1a)

Metabotropic glutamate receptor 1a (mGluR1a) is a major splice variant of the mGluR1 protein, belonging to the Group I metabotropic glutamate receptors within the Family C G protein-coupled receptor (GPCR) superfamily [1.1.2, 1.2.1]. It is primarily expressed in the central nervous system, with particularly high density in the cerebellar Purkinje cells, hippocampus, and thalamus, where it plays a critical role in modulating excitatory neurotransmission and synaptic plasticity, including long-term depression (LTD) [1.1.1, 1.3.1]. Upon activation by its endogenous ligand, L-glutamate, mGluR1a primarily couples to Gq/11 proteins to trigger the phospholipase C signaling cascade, resulting in intracellular calcium mobilization and protein kinase C activation [1.1.4, 1.2.3]. Dysregulation of mGluR1a signaling is implicated in various neurological and psychiatric conditions, such as spinocerebellar ataxias, epilepsy, schizophrenia, and neurodegenerative diseases like Alzheimer's [1.1.3, 1.4.3]. Furthermore, ectopic expression of mGluR1a has been linked to the progression of certain cancers, notably melanoma [1.2.1]. Therapeutic strategies targeting mGluR1a include the development of negative allosteric modulators (NAMs) for neuroprotection and positive allosteric modulators (PAMs) for cognitive enhancement [1.2.4]. However, drug development faces significant challenges regarding motor-related side effects, such as ataxia, due to the receptor's vital role in cerebellar function [1.1.1]. Research in rat models has been pivotal in defining these physiological roles and identifying potential therapeutic windows for mGluR1a-targeted compounds [1.3.2, 1.4.2].

Other names

Grm1GRM1mGlu1aMetabotropic glutamate receptor 1 alphaGPRC1AMGLU1MGLUR1PPP1R85SCAR13SCA44

mGluR1a acts as a G protein-coupled receptor that primarily couples to the Gq/11 signaling pathway. Upon binding of the endogenous ligand L-glutamate, the receptor activates phospholipase C (PLC), which catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). This leads to the release of calcium from intracellular stores and the activation of protein kinase C (PKC), which subsequently modulates ion channel activity and synaptic strength [1.1.1, 1.1.4, 1.2.3].